Christopher Sweeney

36PUBLICATIONS
269CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsLiquid biopsiesApplied geophysics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (36)

|Jul 08, 2026
Development and Validation of a Computational Histology Artificial Intelligence-Powered Biomarker in Metastatic Hormone-Sensitive Prostate Cancer on Randomized Phase III Trials.

|Jun 26, 2026
AI-Based Pathology classifier Predicts Sensitivity to Enzalutamide in Metastatic Hormone-Sensitive Prostate Cancer: A Biomarker Analysis of the ENZAMET Trial.

|Apr 29, 2026
A Gene Expression Tumor Signature Optimizing Partial Area-Under-the-Curve (pAUC) to Improve Specificity for Indolent Prostate Cancer.

|Dec 16, 2025
Early favorable prostate-specific antigen response prediction in metastatic hormone sensitive prostate cancer.

Soumyajit Roy, Yilun Sun, Maha Hussain

|Dec 01, 2025
A Computational Pathology Model to Predict Docetaxel Benefit in Localized High-Risk and Metastatic Prostate Cancer.

Sebastian Medina, Naoto Tokuyama, Kamal Hammouda

|Nov 27, 2025
Personalized intensification of treatment for hormone-sensitive prostate cancer.

Michael A Cilento, Lisa M Butler, Louise Emmett

Pageof 6

Frequent Collaborators

5 joint publications

Atish D Choudhury

5 joint publications

Silke Gillessen

5 joint publications

Martin R Stockler

5 joint publications

Ian D Davis